Showing 3921-3930 of 10623 results for "".
Analyzing a Mobile App’s Impacts on COVID-19 Vaccine Trust in Young Black Adults
https://reachmd.com/programs/clinicians-roundtable/analyzing-a-mobile-apps-impacts-on-covid-19-vaccine-trust-in-young-black-adults/36411/The Psychosocial Dermal Axis
https://reachmd.com/topics/skincare/the-psychosocial-dermal-axis/35421/It’s time for psychiatry, dermatology, and aesthetic medicine to unite and explore.A Clinician's Guide to the ACIP Travel Vaccination Recommendations
https://reachmd.com/programs/vaccination/a-clinicians-guide-to-the-acip-travel-vaccination-recommendations/26483/Get ready to integrate the latest ACIP updates into practice to improve patient care and public health outcomes with this essential recap.Sussing Out Small Bowel Bleeding: Key Evaluation Tools to Know
https://reachmd.com/programs/gi-insights/sussing-out-small-bowel-bleeding-key-evaluation-tools-to-know/13119/Do you suspect your patient might have small bowel bleeding—despite a massive workup? These evaluation tools can help you find out.Monoclonal Antibody Treatment for COVID-19 Receives FDA Authorization
https://reachmd.com/programs/the-drug-report/monoclonal-antibody-treatment-for-covid-19-receives-fda-authorization/12008/The FDA has granted Emergency Use Authorization, or EUA, for Eli Lilly and Company’s investigational COVID-19 treatment.Cardio-Oncology: An Emerging Field to Improve Cardiovascular Care for Cancer Patients
https://reachmd.com/programs/advanced-treatments-innovations-mayo-clinic/cardio-oncology-an-emerging-field-to-improve-cardiovascular-care-for-cancer-patients/11448/Since cancer treatments can impact a patient’s cardiovascular health, how can specialists in these two fields work together to improve care?Is Primary Care Taking Full Advantage of Physical Therapy?
https://reachmd.com/programs/everyday-family-medicine/is-primary-care-taking-full-advantage-of-physical-therapy/10786/Referral rates to physical therapists dropped 50 percent from 2003 to 2014, but it’s not too late for primary care physicians to reverse that trend.Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
https://reachmd.com/programs/global-neurology-academy/now-approved-europe-first-oral-short-course-treatment-highly-active-relapsing-ms/9779/European Commission Grants Approval for Mavenclad (Cladribine Tablets)Unusual Transplant-associated Infections: Just How Unusual?
https://reachmd.com/programs/grand-rounds-nation/unusual-transplant-associated-infections-just-how-unusual/7248/Transplant centers have very little time to evaluate if the need for transplant for a particular recipient outweighs the possible risk of infection from a potential donor. In the case of transplants from deceased donors, time and other factors limit the testing that can be performed prior to transplNew Frontiers in Regenerative Medicine
https://reachmd.com/programs/second-opinion-live/new-frontiers-in-regenerative-medicine-1/6233/This week's guest is Dr. Anthony Atala, who oversees the world's largest lab devoted to bioengineering body parts, from inkjet-printed hearts to tiny livers, at Wake Forest University in Winston-Salem, North Carolina. He gives us an update from the cutting edge of medicine. Also, we get to the botto